CAMBRIDGE, Mass., Nov. 7 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. announced today that management will present at Deutsche Bank’s 2008 Biotech Boston Confab on Tuesday, November 11th at 9:40 a.m. ET.
The live and archived webcast of the presentation can be accessed under “Calendar of Events” in the Idenix Investor Center at http://www.idenix.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix’s current focus is on the treatment of infections caused by the hepatitis C virus and HIV. For further information about Idenix, please refer to http://www.idenix.com.
Idenix Pharmaceuticals’ Contacts:
Media: Teri Dahlman (617) 995-9905
Investors: Amy Sullivan (617) 995-9838
CONTACT: Media, Teri Dahlman, +1-617-995-9905, or Investors, Amy Sullivan,
+1-617-995-9838, both of Idenix Pharmaceuticals, Inc.
Web site: http://www.idenix.com/
